Melinta Therapeutics, LLC
UnclaimedPharmaceutical Preparation ManufacturingParsippany, NJ
Founded
2005
Primary NAICS
325412
CAGE code
7XFT1
Federal awards
$47.5M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)Corporate, Subsidiary, and Regional Managing OfficesDrugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 9 |
| 2025 | Department of Health and Human Services | $21,335,789 | 3 |
| 2025 | Department of Veterans Affairs | $0 | 5 |
| 2024 | Department of Health and Human Services | $5,662,702 | 2 |
| 2024 | Department of Veterans Affairs | $0 | 13 |
| 2023 | Department of Health and Human Services | $20,522,757 | 1 |
| 2023 | Department of Veterans Affairs | $0 | 4 |
| 2022 | Department of Veterans Affairs | $0 | 3 |